Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04947735 · ClinicalTrials.gov registry record · NA
CYPRESS Efficacy and Safety Study Extension
A NA study of Myopia and Juvenile Myopia, sponsored by SightGlass Vision.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 12
- Study locations
NCT04947735 is a NA study of Myopia and Juvenile Myopia that is active but no longer recruiting, run by SightGlass Vision. The registered enrollment target is 200 participants, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (25% lower). The trial reports 12 study locations across 11 states.
The verdict
NCT04947735, a NA study of Myopia and Juvenile Myopia, is active but no longer recruiting, sponsored by SightGlass Vision.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 12
- Study locations
Study Summary
This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.
Conditions Studied
Interventions
- DEVICE Novel spectacle lens design
- DEVICE Spectacle lenses
Study Locations (12)
New York
- SUNY School of Optometry - New York
- Sacco Eye Group - Vestal
California
- Golden Optometric Group - Whittier
Florida
- Omega Vision Center, PA - Longwood
Kansas
- Kannarr Eye Care - Pittsburg
Louisiana
- Haik Humble - West Monroe
Missouri
- Advanced Eyecare PC - Raytown
South Dakota
- Dunes Eye Consultants - Dakota Dunes
Tennessee
- Total Eye Care - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-07-19 |
| Est. Completion | 2026-03-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04947735
The ClinicalTrials.gov registry entry for NCT04947735 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 90 other Myopia trials with a reported enrollment target (25% lower). The listed sponsor is SightGlass Vision, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which Novel spectacle lens design is the first listed.
NCT04947735 reports 12 study locations spanning 11 distinct geographic areas - top geographies include New York, California, Florida.
Frequently Asked Questions
What is clinical trial NCT04947735 about?
NCT04947735 is a clinical study titled "CYPRESS Efficacy and Safety Study Extension". This is an open-label, controlled, multisite, two-arm parallel group clinical trial of 36-month duration to evaluate the continued safety and efficacy of SightGlass Vision Diffusion Optics Technology (DOT) Spectacles in reducing the progression of juvenile myopia.
What is the current status of trial NCT04947735?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2021-07-19. Estimated completion is 2026-03-31.
What conditions does trial NCT04947735 study?
This clinical trial studies the following conditions: Myopia, Juvenile Myopia.
What interventions are being tested in trial NCT04947735?
The interventions under investigation include: Novel spectacle lens design (DEVICE), Spectacle lenses (DEVICE).
Who is sponsoring clinical trial NCT04947735?
This trial is sponsored by SightGlass Vision, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04947735 being conducted?
This trial has 12 study locations across California, Florida, Kansas, Louisiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
-
Wavelength Intervention for Nearsighted Kids
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.